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ABSTRACT
Objective: To evaluate the relation between diabetes-related distress 
and the clinical and sociodemographic characteristics of type 2 
diabetes mellitus patients. Methods: A cross-sectional study based 
on a secondary analysis of data collected at a specialized care 
outpatient center in Brazil. Participants completed a questionnaire 
on sociodemographic and clinical characteristics and the Brazilian 
version of the Diabetes Distress Scale (B-DDS). Results: About 31% 
of the 130 eligible patients reported diabetes distress, and the mean 
B-DDS score was 2.6. Multiple regression analysis showed the B-DDS 
score was positively correlated with marital status (p=0.0230), use 
of diet and physical activities for diabetes management (p=0.0180), 
and use of insulin therapy (p=0.0030). The “emotional burden”, 
“regimen-related distress”, and “interpersonal distress” domains 
from B-DDS were associated with the use of insulin therapy 
(p=0.0010), marital status (p=0.0110), and the presence of three 
or more comorbidities (p=0.0175). Conclusion: These findings 
suggest the clinical and sociodemographic variables are relatively 
weak predictors of diabetes-related distress. The highest scores in 
the B-DDS were observed in the emotional burden domain, indicating 
the presence of diabetes distress among the participants of the study.
Keywords: Diabetes mellitus, type 2; Stress, psychological; Diabetes 
complications; Public health nursing
RESUMO
Objetivo: Avaliar a relação entre o estresse relacionado ao diabetes 
e as características clínicas e sociodemográficas de pacientes com 
diabetes mellitus do tipo 2. Métodos: Estudo transversal com base 
na análise secundária de dados coletados em um ambulatório de 
atendimento terciário no Brasil. Os participantes preencheram um 
questionário sobre as características sociodemográficas e clínicas, e 
a versão brasileira da Diabetes Distress Scale (B-DDS). Resultados: 
Aproximadamente 31% dos 130 pacientes elegíveis relataram estresse 
relacionado ao diabetes, e a média do escore da B-DDS foi de 2,6. 
O modelo de regressão múltipla mostrou que a pontuação B-DDS foi 
positivamente correlacionada com o estado civil (p=0,0230), realização 
de dieta e atividades físicas (p=0,0180), e uso de insulina (p=0,0030). 
Os domínios da B-DDS “carga emocional”, “estresse relacionado ao 
regime terapêutico” e “estresse nas relações interpessoais” foram 
associados a uso de insulina (p=0,0010), estado civil (p=0,0110) e 
presença de três ou mais comorbidades (p=0,0175). Conclusão: Estes 
resultados sugerem que as variáveis clínicas e sociodemográficas são 
preditores relativamente fracos para o estresse relacionado ao diabetes. 
No domínio “carga emocional”, foi observada a maior pontuação da 
B-DDS, indicando a presença do estresse relacionado ao diabetes entre 
os pacientes deste estudo.
Descritores: Diabetes mellitus tipo 2; Estresse psicológico; Complicações 
do diabetes; Enfermagem em saúde pública
INTRODUCTION
Today, the non-communicable chronic diseases represent 
an important public health problem worldwide, since 
they are associated with high rates of morbidity and 
mortality and high costs to public health systems.(1,2) 
Type 2 diabetes mellitus (DM2) gets attention because 
of its chronic nature and high incidence worldwide. 
The International Diabetes Federation (IDF) reported 
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there were approximately 382 million people with DM2 
in 2013 all over the world, and that this number was 
expected to increase to 592 million by 2035.(3)
The objective of DM2 treatment should be to achieve 
adequate metabolic control, thus preventing long-term 
chronic complications, which are the main cause of 
mortality among these individuals.(1-3) DM2 is a complex 
condition, and effective management depends on self-
care activities and on patient’s barriers to implement 
capillary glucose monitoring and insulin therapy.(4,5)
Self-management of DM2, patients’ concerns about 
their health condition, and the possibility of developing 
complications may lead to emotional stress, a condition 
referred to as diabetes-related distress.(6,7) This is defined 
as an emotional reaction to the various situations the 
patient must deal with on an everyday basis, which may 
have a temporary or permanent negative impact, in the 
form of negative feelings, such as irritability, sadness, and 
fear related to the difficulty in controlling the disease.(6,8,9)
Diabetes-related distress may have a significant 
influence on glycemic control. Distress may act directly 
to deregulate stressor hormones or indirectly, as a 
higher emotional burden reduces compliance with 
diabetes mellitus (DM) treatment regimes.(6,10,11) This 
means that patients may be exposed to a higher risk of 
hyperglycemia, and a poor glycemic control may lead to 
severe complications and development of comorbidities.
Diabetes-related distress is often confused with 
depression, but although it is closely related to depression, 
it is important to distinguish between them if adequate 
treatment is to be provided.(6) It has been reported that 
nearly a quarter of all individuals diagnosed with DM2 
suffer from depressive symptoms or emotional stress 
related to DM2, and about 18 to 45% of DM2 patients 
are diagnosed with diabetes-related distress.(1,12,13) Both 
depression and diabetes-related distress may interfere 
with glycemic control and result in elevated glycated 
hemoglobin A1c (HbA1c) levels. Some studies indicate 
that diabetes-related distress is a better predictor of 
hyperglycemia than depression, but evidence is not 
clear.(14,15) Diabetes-related distress is also considered a 
risk factor for depression, which is associated with increased 
morbidity and mortality.(16) Behavioral interventions 
showed to be promising as a means of enabling patients 
to manage the emotional burden inherent to DM2, 
hence improving psychological well-being and diabetes-
related health outcomes.(17)
The American Diabetes Association recommends 
routine monitoring of diabetics for psychological 
problems, such as diabetes-related distress.(1) Emotional 
well-being is important in managing diabetes, because 
social and psychological problems may impair the ability 
of the patient and his or her family to treat the DM2, thus 
having greater negative influence on health status.(18-20) 
Clinicians treating DM2 patients should, therefore, 
monitor patients’ psychosocial status so that they can 
offer interventions as necessary.
Healthcare professionals should have a good 
understanding of diabetes-related distress to be capable 
of recognizing the condition and offering affected 
patients better support so that they are better able to 
cope with their disease. 
OBJECTIVE
To evaluate the relation between diabetes-related distress 
and the clinical and sociodemographic characteristics of 
type 2 diabetes mellitus patients.
METHODS
Study design and patient selection
This cross-sectional study was undertaken in an outpatient 
center specialized in DM, arterial hypertension, and 
obesity at a teaching hospital in the city of São Paulo 
(SP), Brazil. The outpatient clinic and provides services 
to patients with complex needs, seen by the Sistema Único 
de Saúde (SUS) [Brazilian Unified Health System]. The 
participants were recruited consecutively between May 
and October 2012. The sample comprised 140 men 
and women, aged 18 years or over, who had been 
diagnosed as DM2 at least 1 year before, and were on 
oral antidiabetic agents and/or insulin. The participants 
were required to have sufficient verbal skills to answer 
the questionnaires. Exclusion criteria were patients on 
hemodialysis or with amaurosis.
Data collection
Data were collected through individual interviews, 
which took place in a private environment. Social and 
demographic data (age, sex, schooling level, marital 
status, employment situation, and individual monthly 
income), and clinical data (time since diagnosis, 
comorbidities, treatment, and HbA1c level) were 
gathered. Later, the Brazilian version of the Diabetes 
Distress Scale (B-DDS) was applied.
Measurements
The Diabetes Distress Scale (DDS) was developed in 
the United States, in 2005, from three other scales: the 
Measurement of Emotional Adjustment in Diabetic 
Patients (ATT39), the Questionnaire on Stress in 
Patients with Diabetes--Revised (QSPD-R) and the 
Problem Areas in Diabetes (PAID) scale.(7) A Brazilian 
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version of DDS was produced in 2011 and validated in 
2015.(21,22) The final Brazilian version consists of 17 items, 
divided into four subscales: emotional burden (5 items), 
physician-related distress (4 items), regimen-related 
distress (5 items) and interpersonal distress (3 items).
Patients responded the items on the B-DDS using 
a 6-point Likert scale ranging from 1 (non-problem) 
to 6 (serious problem), to indicate how much diabetes-
related stress they had experienced over the previous 
month. Item scores are averaged to a total score between 
1 and 6, thus higher values indicate greater distress and 
subscale scores are the averages of scores for the items 
making up that subscale. Scores of 3 or more indicate 
that the respondent is suffering from diabetes-related 
distress. Total scores of 3 or higher are considered to 
reflect clinically meaningful distress levels.(7,21,22)
Statistical analysis
Qualitative variables were reported as frequencies 
and percentages, and descriptive statistics (mean and 
standard deviation) were calculated. We also prepared 
five multiple linear regression models, with B-DDS 
subscale scores as dependent variables, and the other 
investigated variables as independent ones.(23) In these 
models, the Stepwise criterion was applied, as well as the 
Box-Cox transformation with the dependent variables. 
We calculated regression coefficients, the related 
confidence intervals and p values. We also calculated 
the R² coefficient value for each of the adjusted models. 
Cohen suggested the following criteria for evaluating 
R²: 0.1 to 0.29 as weak; 0.3 to 0.49 as moderate; ≥0.5 as 
strong.(24) A significance level of 5% was applied to all 
tests. Analyses were carried out with Statistical Analysis 
System (SAS) statistical software, version 9.4.
Ethical considerations
The participants were informed as to the objective, 
procedures, risks and benefits of this study. This 
project was approved by the local Ethics Committee, 
under protocols number 1.169.686, and CAAE: 
46860015.8.0000.5404; all participants signed a written 
Informed Consent Form. Our study complies with the 
Declaration of Helsinki on medical research involving 
human subjects.
RESULTS
A total of 140 DM2 were recruited. Ten patients were 
excluded after preliminary data analysis because of 
missing values; hence, the final sample had 130 patients. 
The sociodemographic and clinical profile of the sample 
is presented on table 1. More than half the participants 
Table 1. Social, demographic, and clinical characteristics of patients 
Sociodemographic and clinical variables n (%)
Sex
Female 72 (55.4)
Male 58 (44.6)
Age, years
Mean (SD) 60.4 (9.4) 
Individuals <60 62 (47.7)
Individuals ≥60 68 (52.3)
Marital status
Without a life partner 43 (33.1)
With a life partner 87 (66.9)
Schooling level, years
≤4 84 (64.6)
5-8 18 (13.9)
≥9 28 (21.5)
Employment status
Active 48 (36.9)
Retired 61 (46.9)
Non active 21 (16.2)
Household income (number of minimum monthly wages)*
Mean (SD) 3.1 (2.4)
≤2 54 (41.5)
>2 e ≤4 41 (31.5)
>4 35 (27.0)
Time since diagnosis, years
≤5 38 (29.2)
>5 92 (70.8)
HbA1C
Mean (SD) 8.6 (1.9)
<7 31 (23.8)
≥7 99 (76.2)
Comorbidities
<3 58 (44.6)
≥3 72 (55.4)
BMI
Normal 30 (23.1)
Overweight 45 (34.6)
Obese 55 (42.3)
Use of diet and physical exercise to manage disease (self-reported)
No 30 (23.1)
Yes 100 (76.9)
Use of oral antidiabetic agents
No 22 (16.9)
Yes 108 (83.1)
Use of insulin
No 58 (44.6)
Yes 72 (55.4)
Number of medicines taken
<5 28 (21.5)
≥5 102 (78.5)
Experienced a hypoglycemic episode during the last month
No 81 (62.3)
Yes 49 (37.7)
*US$ 300.00. SD: standard deviation; BMI: body mass index; HbA1C: hemoglobin A1c.
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were at least 60 years old (52.3%), living with a partner 
(66.9%), had 4 years or less of schooling (64.6%), and 
had a monthly income of less than two minimum wages 
(41.5%). A large majority of the sample (70.8%) had 
had DM2 for more than 5 years, 55.4% were on insulin, 
and 55.4% had three or more comorbidities. Just over 
three quarters of the participants (76.9%) reported that 
they engaged in regular physical exercise and followed 
a healthy diet.
Brazilian version of the Diabetes Distress Scale and 
subscales
The prevalence of diabetes-related distress (B-DDS 
score ≥3) was 31.5%. The mean total B-DDS score 
was 2.6 (standard deviation 1.07); the domain that 
attracted the highest mean score was “emotional burden” 
(Table 2). Table 3 presents the demographic and clinical 
variables associated with one or more B-DDS domains. 
“Emotional burden”, “regimen-related distress”, and 
“interpersonal distress” were related to use of insulin 
therapy (p=0.0010), marital status (p=0.0110) and 
presence of three or more comorbidities (p=0.0175), 
respectively. The total B-DDS score was associated 
with marital status (p=0.0230), use of diet and physical 
activity to manage the disease (p=0.0180) and use of 
insulin therapy (p=0.0030).
DISCUSSION
To the best of our knowledge, this is the first study to use 
the B-DDS in a clinical context, in an effort to provide 
new information about the relation between diabetes-
related distress and various social, demographic, and 
clinical variables in DM2 patients. Our sample consisted 
of patients attending a tertiary care outpatient center. 
Most participants were senior citizens, lived with a 
partner, had limited education and a low income, and 
had been diagnosed with DM2 more than 5 years before 
the study.
The prevalence of diabetes-related distress in the 
sample was 31.5%, which is within the range of rates 
reported in other studies (10 to 45%).(1,4,12,13) We found 
that use of insulin therapy was correlated with the score 
on the emotional burden subscale of the B-DDS, but 
the results from the linear regression analyses showed 
that its variables were very weak predictors of diabetes-
related distress (R2=0.13). A prior study found that 
the need to begin insulin therapy had very negative 
connotations for people with DM2.(25)
Patients who use insulin require frequent monitoring 
of capillary glycemia, food fractioning may restrict 
their daily activities, and management of these factors 
demands that the individual’s complex competence 
level be good. Changes in emotional distress may be 
better explained by changes in subjective variables such 
as coping style and perceived support than by changes 
in clinical characteristics.(26)
Regimen-related distress was significantly associated 
with living with a life partner, but proved a weak 
predictor of diabetes-related distress. The presence of a 
life partner may influence the daily self-care regime of 
patients, as they may be subjected to more supervision 
and be warned frequently by their partner about the 
need to pay attention to their disease, thus generating 
higher levels of diabetes-related distress.(27) It is also 
possible that partners may deal with the DM2 patient’s 
Table 2. Average score of Brazilian version of the Diabetes Distress Scale 
B-DDS Mean (SD)
Emotional burden 3.2 (1.45)
Physician-related distress 2.0 (1.35)
Regimen-related distress 2.5 (1.38)
Interpersonal distress 2.0 (1.41)
Total score 2.6 (1.07)
B-DDS: Brazilian version of the Diabetes Distress Scale; SD: standard deviation.
Table 3. Factors associated with diabetes-related distress
B
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Dependent variable Independent variables Coefficient
95%CI
p value R²
I.L S.L
Emotional burden Use of insulin (reference category: yes) -0.55 -0.88 -0.23 0.0010 0.13
Regimen-related distress Marital status (reference category: with life partner) -0.25 -0.43 -0.06 0.0110 0.05
Interpersonal distress Comorbidities (reference category: ≥3) -0.13 -0.23 -0.02 0.0175 0.04
Physician-related distress Not associated with any of the variables investigated
Total DDS score Marital status (reference category: with life partner) -0.16 -0.29 -0.02 0.0230 0.13
Manage disease with diet and exercise (reference category: yes) 0.18 0.03 0.33 0.0180
Use of insulin (reference category: yes) -0.20 -0.32 -0.07 0.0030
95%CI: 95% confidence interval; I.L: inferior limit; S.L: superior limit; B-DDS: Brazilian version of the Diabetes Distress Scale.
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health condition in a more caring way, and try to hide 
or disguise their concerns about the progress of the 
patient’s disease and his or her condition. This strategy 
could have a negative impact on self-management of 
the disease.(28)
The presence of three or more comorbidities was 
significantly associated with interpersonal distress in 
DM2 patients; nonetheless, this was a weak predictor of 
diabetes-related distress. The presence of comorbidities, 
which are very common, was negatively associated with 
quality of life in patients with DM2.(29) Another study 
reported that diabetes-related distress as measured with 
the DDS was negatively associated with quality of life.(30)
Although the independent variables “insulin 
treatment”, “living with a life partner”, and “presence of 
three or more comorbidities” were not strong predictors 
of scores on any of the B-DDS subscales, the evaluation 
of diabetes-related distress showed high distress 
prevalence in people with DM2, corroborating the 
previous studies.(1,4,12,13)
Additionally, we have found that most patients 
are overweight or obese and that HbA1C was higher 
than >7.0%, even though most patients self-report as 
following a diet and engaging in physical exercise to 
manage disease. Our results suggest that compliance 
with dietary guidelines or physical exercise is poor, 
and the misperception perhaps happens because 
patients understand that weight and physical exercise 
management is important for their health. Few studies 
have investigated associations between diabetes-related 
distress and self-management behaviors of diet and 
physical exercise; a recent study demonstrated that 
distress or depressive symptoms are associated with 
worse self-management behaviors in diabetic patients, 
and attention of the healthcare professionals to mental 
health status helps improve compliance with diet and 
physical exercise recommendations.(31)
In spite of the fact that DDS17 is not a short scale, 
the use of this tool contributed to screening and 
assessing diabetes-related emotional distress in clinical 
practice. Another possibility is to use DDS2 in 
clinical consultations, with a short form of DDS17. A 
study showed that the DDS2 is easier for addressing 
psychological issues, but this scale does not have as 
strong a relation with glycemia control as DDS17.(32) 
The limitations of this study should be taken 
into account when interpreting the results. First, we 
used secondary data from previous research with a 
small sample. Cohort studies should be conducted in 
order to better explore demographic and clinical 
variables in diabetes-related distress. Second, the study 
was based on a sample of DM2 patients treated in a 
general adult outpatient center, and our sample may 
not be representative of the population of diabetics. Our 
participants may have been generally more severely 
affected by the disease than patients treated in primary 
care settings. Third, the study did not collect data on 
the incidence of chronic complications, which predict 
diabetes-related distress.
Our findings confirm that there is a correlation 
between the diabetes-related distress and DM2, which 
is a challenge for healthcare systems. The healthcare 
providers should organize to offer support and 
education on self-care addressing healthy lifestyle, use of 
medications, strategies for emotional stress and behavior 
change, aiming to maintain optimal metabolic control. 
Using specific scales to evaluate diabetes-related distress 
may improve overall disease management by enabling 
individual stress factors to be identified in a timely 
manner; this would enable appropriate intervention to 
be offered more promptly.
CONCLUSION
Our study provided new information about the 
connection between diabetes-related distress and 
social, demographic, and clinical variables in adult 
type 2 diabetes mellitus patients. These variables are 
relatively weak predictors of diabetes-related distress 
as measured by the Diabetes Distress Scale. The mean 
Diabetes Distress Scale total score in our sample 
showed moderate patient distress, and the emotional 
burden domain had the highest scores (which indicate 
greater distress). Health professionals should put forth 
more effort to identify patients in whom type 2 diabetes 
mellitus has a negative psychological impact, help them 
with the self-management of their disease, and refer 
them to programs that can offer the support necessary.
ACKNOWLEDGEMENTS
The study participants, for their involvement in this 
research project, and Marcos Sérgio Zanchetta Jr., for 
the translation of this article.
REFERENCES
1. American Diabetes Association. Standards of medical care in diabetes--2014. 
Diabetes Care. 2014;37 Suppl 1:S14-80.
2. Png ME, Yoong JS. Evaluating the cost-effectiveness of lifestyle modification 
versus metformin therapy for the prevention of diabetes in Singapore. PLoS 
One. 2014;9(9):e107225. eCollection 2014. Erratum in: PloS One. 2015;10(3): 
e0120831. 
3. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. 
Global estimates of diabetes prevalence for 2013 and projections for 2035. 
Diabetes Res Clin Pract. 2014;103(2):137-49.
351Clinical and sociodemographic variables associated with diabetes-related distress in patients with type 2 diabetes mellitus
einstein. 2016;14(3):346-51
4. Hlatky MA, Chung SC, Escobedo J, Hillegass WB, Melsop K, Rogers W, Brooks 
MM; BARI 2D Study Group. The effect of obesity on quality of life in patients 
with diabetes and coronary artery disease. Am Heart J. 2010;159(2):292-300.
5. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients 
with diabetes: a systematic review from the European depression in diabetes 
(EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112-9. Review.
6. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress 
in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015;3(6):450-60. 
Review.
7. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing 
psychosocial distress in diabetes: development of the diabetes distress 
scle. Diabetes Care. 2005;28(3):626-31.
8. Ridner SH. Psychological distress: concept analysis. J Adv Nurs. 2004;45(5): 
536-45. Review.
9. Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress 
clinically meaningful?: establishing cut points for the Diabetes Distress Scale. 
Diabetes Care. 2012;35(2):259-64.
10. Tabák AG, Akbaraly TN, Batty GD, Kivimäki M. Depression and type 2 diabetes: 
a causal association? Lancet Diabetes Endocrinol. 2014;2(3):236-45. Review.
11. Gonzalez JS, Shreck E, Psaros C, Safren SA. Distress and type 2 diabetes-
treatment adherence: a mediating role for perceived control. Health Psychol. 
2015;34(5):505-13.
12. Snoek FJ, Kersch NY, Eldrup E, Harman-Boehm I, Hermanns N, Kokoszka A, et 
al. Monitoring of Individual Needs in Diabetes (MIND): baseline data from the 
Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. 
Diabetes Care. 2011;34(3):601-3.
13. Pouwer F, Wijnhoven HA, Ujcic-Voortman JK, de Wit M, Schram MT, Baan 
CA, et al. Ethnic aspects of emotional distress in patients with diabetes--the 
Amsterdam Health Monitor Study. Diabet Med. 2013;30(1):e25-31.
14. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes 
distress but not clinical depression or depressive symptoms is associated 
with glycemic control in both cross sectional and longitudinal analyses. 
Diabetes Care. 2010;33(1):23-8.
15. Gonzalez JS, Delahanty LM, Safren SA, Meigs JB, Grant RW. Differentiating 
symptoms of depression from diabetes-specific distress: relationships with 
self-care in type 2 diabetes. Diabetologia. 2008;51(10):1822-5.
16. Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. 
Depression and advanced complications of diabetes: a prospective cohort 
study. Diabetes Care. 2010;33(2):264-9.
17. Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, et al. The 
effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) 
for patients with diabetes and subclinical depression: results of a randomized 
controlled trial. Diabetes Care. 2015;38(4):551-60.
18. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse 
RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the 
literature. Int J Psychiatry Med. 2002;32(3):235-47. Review.
19. Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, et al. 
Association of diabetes-related emotional distress with diabetes treatment in 
primary care patients with type 2 diabetes. Diabet Med. 2007;24(1):48-54.
20. Kovacs Burns K, Nicolucci A, Holt RI, Willaing I, Hermanns N, Kalra S, Wens J, 
Pouwer F, Skovlund SE, Peyrot M; DAWN2 Study Group. Diabetes Attitudes, 
Wishes and Needs second study (DAWN2TM): cross-national benchmarking 
indicators for family members living with people with diabetes. Diabet Med. 
2013;30(7):778-88.
21. Curcio R, Alexandre NM, Torres HC, Lima MH. Tradução e adaptação do 
“Diabetes Distress Scale - DDS” na cultura brasileira. Acta Paul Enferm. 2012; 
25(5):762-7.
22. Apolinario PP, Trevisan DD, Rodrigues RC, Jannuzzi FF, Ferreira JF, de Oliveira 
HC, et al. Psychometric Performance of the Brazilian Version of the Diabetes 
Distress Scale (B-DDS) in Patients With Diabetes Mellitus type 2. J Nurs Meas. 
2016;24(2):101-13.
23. Montgomery DC, Peck EA, Vining GG. Introduction to linear regression analysis. 
New York: John Wiley; 1982.
24. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New 
Jersey: Lawrence Erlbaum Associates; 1988.
25. Wang HF, Yeh MC. Psychological resistance to insulin therapy in adults with 
type 2 diabetes: mixed-method systematic review. J Adv Nurs. 2012;68(4): 
743-57. Review.
26. Karlsen B, Oftedal B, Bru E. The relationship between clinical indicators, 
coping styles perceived support and diabetes-related distress among adults 
with type 2 diabetes. J Adv Nurs. 2012;68(2):391-401.
27. Rook KS, August KJ, Choi S, Franks MM, Stephens MA. Emotional reactivity 
to daily distress, spousal emotional support, and fasting blood glucose 
among patients with type 2 diabetes. J Heath Psychol. 2015 May 7. [Epub 
ahead of print].
28. Johnson MD, Anderson JR, Walker A, Wilcox A, Lewis VL, Robbins DC. 
Spousal protective buffering and type 2 diabetes outcomes. Health Psychol. 
2014;33(8):841-4.
29. Adriaanse MC, Drewes HW, van der Heide I, Struijs JN, Baan CA. The impact 
of comorbid chronic conditions on quality of life in type 2 diabetes patients. 
Qual Life Res. 2016;25(1):175-82.
30. Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N. Research: 
educational and psychological aspects how to assess diabetes distress: 
comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes 
Distress Scale (DDS). Diabet Med. 2015;33(6):835-43.
31. Johnson ST, Al Sayah F, Mathe N, Johnson JA. The relationship of diabetes-
related distress and depressive symptoms with physical activity and dietary 
behaviors in adults with physical activity and dietary behaviors in adults with 
type 2 diabetes: a cross-sectional study. J Diabetes Complications. 2016; 
30(5):967-70.
32. Johansen CB, Torenholt R, Hommel E, Wittrup M, Willaing I. A consultation 
dialogue tool helps address psychological aspects of diabetes. Diabet Med. 
2014;31(12):1708-9.
